Insmed Inc (NASDAQ:INSM)
| 19.02 Delayed Data As of 4:00pm ET |  +0.33 / +1.77%Today’s Change | 16.04 Today|||52-Week Range 28.94 | -4.80% Year-to-Date |
Latest INSM News | Press Releases
No recent news for Insmed Inc.
Today’s Trading
| Previous close | 18.69 |
| Today’s open | 18.99 |
| Day’s range | 18.69 - 19.14 |
| Volume | 26,076 |
| Average volume (3 months) | 1,162,318 |
| Market cap | $2.6B |
Data as of 4:00pm ET, 05/31/2023
Growth & Valuation
| Earnings growth (last year) | -0.95% |
| Earnings growth (this year) | -15.92% |
| Earnings growth (next 5 years) | +33.50% |
| Revenue growth (last year) | +30.19% |
| P/E ratio | NM |
| Price/Sales | 10.02 |
| Price/Book | 29.03 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| RVNCRevance Therapeutics... | +0.30 | +0.99% |
| IZQVFIndivior PLC | -0.39 | -2.09% |
| XENEXenon Pharmaceutical... | +0.11 | +0.29% |
| AKROAkero Therapeutics I... | +0.73 | +1.66% |
Data as of 4:00pm ET, 05/31/2023
Financials
| Next reporting date | August 3, 2023 |
| EPS forecast (this quarter) | -$1.12 |
| Annual revenue (last year) | $245.4M |
| Annual profit (last year) | -$481.5M |
| Net profit margin | -196.26% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Bridgewater, New Jersey |
Forecasts
